EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Clinical Spectrum of LMNA-Associated Type 2 Familial Partial Lipodystrophy: A Systematic Review

Antia Fernandez-Pombo iD, Everardo Josue Diaz-Lopez iD, Ana I Castro, Sofia Sanchez-Iglesias iD, Silvia Cobelo-Gomez iD, Teresa Prado-Moraña, David Araujo-Vilar iD

Cells · 24.02.2023 · 12 (5) · 725

DOI: 10.3390/cells12050725 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Cells, online erschienen am 24.02.2023. Verfasst von Antia Fernandez-Pombo und 6 weiteren Autor:innen. Beteiligte Einrichtung: UETeM-Molecular Pathology Group, Department of Psychiatry, Radiology, Public Health, Nursing and Medicine, IDIS-CIMUS, University of Santiago de Comp…. Hauptthemen laut MEDLINE: Lipodystrophy, Familial Partial, Insulin Resistance, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Xunta de Galicia, Research Fellowship by the Asociación Española de Familiares y Afectados de Lipodistrofias (AELIP).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 familial partial lipodystrophy (FPLD2) is a laminopathic lipodystrophy due to pathogenic variants in the LMNA gene. Its rarity implies that it is not well-known. The aim of this review was to explore the published data regarding the clinical characterisation of this syndrome in order to better describe FPLD2. For this purpose, a systematic review through a search on PubMed until December 2022 was conducted and the references of the retrieved articles were also screened. A total of 113 articles were included. FPLD2 is characterised by the loss of fat starting around puberty in women, affecting limbs and trunk, and its accumulation in the face, neck and abdominal viscera. This adipose tissue dysfunction conditions the development of metabolic complications associated with insulin resistance, such as diabetes, dyslipidaemia, fatty liver disease, cardiovascular disease, and reproductive disorders. However, a great degree of phenotypical variability has been described. Therapeutic approaches are directed towards the associated comorbidities, and recent treatment modalities have been explored. A comprehensive comparison between FPLD2 and other FPLD subtypes can also be found in the present review. This review aimed to contribute towards augmenting knowledge of the natural history of FPLD2 by bringing together the main clinical research in this field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipodystrophy, Familial PartialInsulin ResistanceDiabetes Mellitus, Type 2HumansFemaleAdipose TissueExtremitiesLamin Type A

Stichwörter der Autor:innen

Dunnigan diseaseFPLD2LMNAlaminopathiestype 2 familial partial lipodystrophy

Substanzen

LMNA protein, humanLamin Type A

Autor:innen und Institutionen

  • UETeM-Molecular Pathology Group, Department of Psychiatry, Radiology, Public Health, Nursing and Medicine, IDIS-CIMUS, University of Santiago de Compostela, 15706 Santiago de Compostela, Spain.
  • Division of Endocrinology and Nutrition, University Clinical Hospital of Santiago de Compostela, 15706 Santiago de Compostela, Spain.
  • CIBER Fisiopatología de la Obesidad y la Nutrición (CIBERobn), 28029 Madrid, Spain.

ORCID-Profile: Antia Fernandez-Pombo, Everardo Josue Diaz-Lopez, Sofia Sanchez-Iglesias, Silvia Cobelo-Gomez, David Araujo-Vilar

Förderung

  • Instituto de Salud Carlos III
  • Xunta de Galicia
  • Research Fellowship by the Asociación Española de Familiares y Afectados de Lipodistrofias (AELIP)

Zitieren

APA

Fernandez-Pombo, A., Diaz-Lopez, E. J., Castro, A. I., Sanchez-Iglesias, S., Cobelo-Gomez, S., Prado-Moraña, T., & Araujo-Vilar, D. (2023). Clinical Spectrum of LMNA-Associated Type 2 Familial Partial Lipodystrophy: A Systematic Review. Cells, 12(5), 725. https://doi.org/10.3390/cells12050725

Vancouver

Fernandez-Pombo A, Diaz-Lopez EJ, Castro AI, Sanchez-Iglesias S, Cobelo-Gomez S, Prado-Moraña T, et al. Clinical Spectrum of LMNA-Associated Type 2 Familial Partial Lipodystrophy: A Systematic Review. Cells. 2023;12(5):725. doi:10.3390/cells12050725

BibTeX
@article{FernandezPombo2023,
  author = {Fernandez-Pombo, Antia and Diaz-Lopez, Everardo Josue and Castro, Ana I and Sanchez-Iglesias, Sofia and Cobelo-Gomez, Silvia and Prado-Moraña, Teresa and Araujo-Vilar, David},
  title = {Clinical Spectrum of LMNA-Associated Type 2 Familial Partial Lipodystrophy: A Systematic Review},
  journal = {Cells},
  year = {2023},
  volume = {12},
  number = {5},
  pages = {725},
  doi = {10.3390/cells12050725}
}
Kostenlos starten →